182 related articles for article (PubMed ID: 27683279)
1. High extent of O-GlcNAcylation in breast cancer cells correlates with the levels of HAS enzymes, accumulation of hyaluronan, and poor outcome.
Tiainen S; Oikari S; Tammi M; Rilla K; Hämäläinen K; Tammi R; Kosma VM; Auvinen P
Breast Cancer Res Treat; 2016 Nov; 160(2):237-247. PubMed ID: 27683279
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival.
Auvinen P; Rilla K; Tumelius R; Tammi M; Sironen R; Soini Y; Kosma VM; Mannermaa A; Viikari J; Tammi R
Breast Cancer Res Treat; 2014 Jan; 143(2):277-86. PubMed ID: 24337597
[TBL] [Abstract][Full Text] [Related]
3. Role of UDP-N-acetylglucosamine (GlcNAc) and O-GlcNAcylation of hyaluronan synthase 2 in the control of chondroitin sulfate and hyaluronan synthesis.
Vigetti D; Deleonibus S; Moretto P; Karousou E; Viola M; Bartolini B; Hascall VC; Tammi M; De Luca G; Passi A
J Biol Chem; 2012 Oct; 287(42):35544-35555. PubMed ID: 22887999
[TBL] [Abstract][Full Text] [Related]
4. Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer.
Auvinen P; Tammi R; Kosma VM; Sironen R; Soini Y; Mannermaa A; Tumelius R; Uljas E; Tammi M
Int J Cancer; 2013 Feb; 132(3):531-9. PubMed ID: 22753277
[TBL] [Abstract][Full Text] [Related]
5. High numbers of macrophages, especially M2-like (CD163-positive), correlate with hyaluronan accumulation and poor outcome in breast cancer.
Tiainen S; Tumelius R; Rilla K; Hämäläinen K; Tammi M; Tammi R; Kosma VM; Oikari S; Auvinen P
Histopathology; 2015 May; 66(6):873-83. PubMed ID: 25387851
[TBL] [Abstract][Full Text] [Related]
6. The reciprocal association between mammographic breast density, hyaluronan synthesis and patient outcome.
Masarwah A; Tammi M; Sudah M; Sutela A; Oikari S; Kosma VM; Tammi R; Vanninen R; Auvinen P
Breast Cancer Res Treat; 2015 Oct; 153(3):625-34. PubMed ID: 26362804
[TBL] [Abstract][Full Text] [Related]
7. Natural antisense transcript for hyaluronan synthase 2 (HAS2-AS1) induces transcription of HAS2 via protein O-GlcNAcylation.
Vigetti D; Deleonibus S; Moretto P; Bowen T; Fischer JW; Grandoch M; Oberhuber A; Love DC; Hanover JA; Cinquetti R; Karousou E; Viola M; D'Angelo ML; Hascall VC; De Luca G; Passi A
J Biol Chem; 2014 Oct; 289(42):28816-26. PubMed ID: 25183006
[TBL] [Abstract][Full Text] [Related]
8. UDP-sugar accumulation drives hyaluronan synthesis in breast cancer.
Oikari S; Kettunen T; Tiainen S; Häyrinen J; Masarwah A; Sudah M; Sutela A; Vanninen R; Tammi M; Auvinen P
Matrix Biol; 2018 Apr; 67():63-74. PubMed ID: 29331336
[TBL] [Abstract][Full Text] [Related]
9. UDP-sugar substrates of HAS3 regulate its O-GlcNAcylation, intracellular traffic, extracellular shedding and correlate with melanoma progression.
Deen AJ; Arasu UT; Pasonen-Seppänen S; Hassinen A; Takabe P; Wojciechowski S; Kärnä R; Rilla K; Kellokumpu S; Tammi R; Tammi M; Oikari S
Cell Mol Life Sci; 2016 Aug; 73(16):3183-204. PubMed ID: 26883802
[TBL] [Abstract][Full Text] [Related]
10. Role of HYAL1 expression in primary breast cancer in the formation of brain metastases.
Witzel I; Marx AK; Müller V; Wikman H; Matschke J; Schumacher U; Stürken C; Prehm P; Laakmann E; Schmalfeldt B; Milde-Langosch K; Oliveira-Ferrer L
Breast Cancer Res Treat; 2017 Apr; 162(3):427-438. PubMed ID: 28168629
[TBL] [Abstract][Full Text] [Related]
11. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.
Karousou E; Misra S; Ghatak S; Dobra K; Götte M; Vigetti D; Passi A; Karamanos NK; Skandalis SS
Matrix Biol; 2017 May; 59():3-22. PubMed ID: 27746219
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome.
Josefsson A; Adamo H; Hammarsten P; Granfors T; Stattin P; Egevad L; Laurent AE; Wikström P; Bergh A
Am J Pathol; 2011 Oct; 179(4):1961-8. PubMed ID: 21854754
[TBL] [Abstract][Full Text] [Related]
13. Cell Energy Metabolism and Hyaluronan Synthesis.
Caon I; Parnigoni A; Viola M; Karousou E; Passi A; Vigetti D
J Histochem Cytochem; 2021 Jan; 69(1):35-47. PubMed ID: 32623953
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan in breast cancer: correlations with nitric oxide synthases and tyrosine nitrosylation.
Karihtala P; Soini Y; Auvinen P; Tammi R; Tammi M; Kosma VM
J Histochem Cytochem; 2007 Dec; 55(12):1191-8. PubMed ID: 17827165
[TBL] [Abstract][Full Text] [Related]
15. A novel role of low molecular weight hyaluronan in breast cancer metastasis.
Wu M; Cao M; He Y; Liu Y; Yang C; Du Y; Wang W; Gao F
FASEB J; 2015 Apr; 29(4):1290-8. PubMed ID: 25550464
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAcylation is associated with the development and progression of gastric carcinoma.
Jang TJ; Kim UJ
Pathol Res Pract; 2016 Jul; 212(7):622-30. PubMed ID: 27131860
[TBL] [Abstract][Full Text] [Related]
17. Metabolic control of hyaluronan synthases.
Vigetti D; Viola M; Karousou E; De Luca G; Passi A
Matrix Biol; 2014 Apr; 35():8-13. PubMed ID: 24134926
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival.
Auvinen P; Tammi R; Parkkinen J; Tammi M; Agren U; Johansson R; Hirvikoski P; Eskelinen M; Kosma VM
Am J Pathol; 2000 Feb; 156(2):529-36. PubMed ID: 10666382
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of nuclear hepatoma-derived growth factor (HDGF) localization in patients with breast cancer.
Chen X; Yun J; Fei F; Yi J; Tian R; Li S; Gan X
Pathol Res Pract; 2012 Aug; 208(8):437-43. PubMed ID: 22682760
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of O-GlcNAc by prostate cancer cells is significantly associated with poor prognosis of patients.
Kamigaito T; Okaneya T; Kawakubo M; Shimojo H; Nishizawa O; Nakayama J
Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):18-22. PubMed ID: 24366413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
